pembrolizumab
merck
['keynote-826']
as bradley j. monk presents final os results from the phase 3 keynote-826 study at #asco23, take a look at additional #cervicalcancer research in #jitc, including this piece from xin huang et al of sun yat-sen university involving genomic profiling: 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)